share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Quincey James

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Quincey James

輝瑞 | 4:持股變動聲明-董事 Quincey James
美股sec公告 ·  07/01 20:49
Moomoo AI 已提取核心訊息
In a recent transaction, Quincey James, a reporting person for Pfizer Inc [PFE], executed a stock transaction on June 28, 2024. The specific details regarding the number of shares involved, the nature of the shares, the transaction price, and the total value of the transaction were not disclosed in the announcement. Additionally, the relationship of Quincey James to Pfizer Inc was not specified, nor was the number of shares held by James after the transaction. This information is typically relevant for investors to assess the potential impact of insider transactions on their investment decisions.
In a recent transaction, Quincey James, a reporting person for Pfizer Inc [PFE], executed a stock transaction on June 28, 2024. The specific details regarding the number of shares involved, the nature of the shares, the transaction price, and the total value of the transaction were not disclosed in the announcement. Additionally, the relationship of Quincey James to Pfizer Inc was not specified, nor was the number of shares held by James after the transaction. This information is typically relevant for investors to assess the potential impact of insider transactions on their investment decisions.
最近,輝瑞公司(Pfizer Inc [PFE])的報告人廓辛·詹姆斯(Quincey James)於2024年6月28日進行了股票交易。公告中未披露涉及的股票數量、股票性質、交易價格以及交易總價值的具體細節。此外,未指明廓辛·詹姆斯與輝瑞公司的關係,也未說明交易後詹姆斯持有的股份數量。投資者通常需要這些信息來評估內幕交易對其投資決策的潛在影響。
最近,輝瑞公司(Pfizer Inc [PFE])的報告人廓辛·詹姆斯(Quincey James)於2024年6月28日進行了股票交易。公告中未披露涉及的股票數量、股票性質、交易價格以及交易總價值的具體細節。此外,未指明廓辛·詹姆斯與輝瑞公司的關係,也未說明交易後詹姆斯持有的股份數量。投資者通常需要這些信息來評估內幕交易對其投資決策的潛在影響。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息